Literature DB >> 18620052

Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients.

Antoine Minne1, Hélène Boireau, Maria Joao Horta, Rita Vanbever.   

Abstract

The aim of this study was to investigate the influence of formulation excipients on physical characteristics of inhalation dry powders prepared by spray-drying. The excipients used were a series of amino acids (glycine, alanine, leucine, isoleucine), trehalose and dipalmitoylphosphatidylcholine (DPPC). The particle diameter and the powder density were assessed by laser diffraction and tap density measurements, respectively. The aerosol behaviour of the powders was studied in a Multi-Stage Liquid Impinger. The nature and the relative proportion of the excipients affected the aerosol performance of the powders, mainly by altering powder tap density and degree of particle aggregation. The alanine/trehalose/DPPC (30/10/60 w/w/w) formulation showed optimal aerodynamic behaviour with a mass median aerodynamic diameter of 4.7 microm, an emitted dose of 94% and a fine particle fraction of 54% at an airflow rate of 100 L/min using a Spinhaler inhaler device. The powder had a tap density of 0.10 g/cm(3). The particles were spherical with a granular surface and had a 4 microm volume median diameter. In conclusion, optimization of the aerosolization properties of inhalation dry powders could be achieved by appropriately selecting the composition of the particles.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18620052     DOI: 10.1016/j.ejpb.2008.06.013

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  6 in total

1.  Spray Dried Rugose Lipid Particle Platform for Respiratory Drug Delivery.

Authors:  Hui Wang; Mani Ordoubadi; Patrick Connaughton; Kellisa Lachacz; Nicholas Carrigy; Scott Tavernini; Andrew R Martin; Warren H Finlay; David Lechuga-Ballesteros; Reinhard Vehring
Journal:  Pharm Res       Date:  2022-04-01       Impact factor: 4.200

2.  Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy.

Authors:  Eleonora Maretti; Luca Costantino; Francesca Buttini; Cecilia Rustichelli; Eliana Leo; Eleonora Truzzi; Valentina Iannuccelli
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

3.  Validation of an HPLC Analytical Method for the Quantitative/Qualitative Determination of Fluticasone Propionate in Inhalation Particles on Several Matrices.

Authors:  André R Sá Couto; Daniela Espinha Cardoso; Helena Maria Cabral-Marques
Journal:  Sci Pharm       Date:  2014-06-16

Review 4.  Imagine the Superiority of Dry Powder Inhalers from Carrier Engineering.

Authors:  Piyush Mehta
Journal:  J Drug Deliv       Date:  2018-01-14

Review 5.  Pulmonary delivery of mucosal nanovaccines.

Authors:  Wei Tang; Yu Zhang; Guizhi Zhu
Journal:  Nanoscale       Date:  2022-01-06       Impact factor: 7.790

6.  Pharmaceutical Benefits of Fluticasone Propionate Association to Delivery Systems: In Vitro and In Vivo Evaluation.

Authors:  Marina G Dogbe; Ambinintsoa Yattussia Mafilaza; Carla Vânia Eleutério; Helena Cabral-Marques; Sandra Simões; Maria Manuela Gaspar
Journal:  Pharmaceutics       Date:  2019-10-10       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.